Orally disintegrating tablets: Products, technologies, and development issues

Pharmaceutical Technology

Volumn 29, Issue 10, 2005, Pages 136-150

  Pfister, William R ^a   Ghosh, Tapash K ^b  

^a NexMed USA Inc   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; MECHANICAL PERMEABILITY; PRODUCT DEVELOPMENT;

ODT PRODUCTS; ORAL DOSAGE; PERMEATION ENHANCERS;

DRUG PRODUCTS;

ALAVERT; ARICEPT ODT; BENADRYL FASTMELT; CAFFEINE; CARBIDOPA PLUS LEVODOPA; CHLORPHENIRAMINE MALEATE; CLARINEX REDITABS; CLONAZEPAM; CLOZAPINE; DESLORATADINE; DIPHENHYDRAMINE; DOMPERIDONE; DONEPEZIL; ENALAPRIL; EXCEDRIN; EXCEDRIN QUICKTABS; FAMOTIDINE; FLUXID; HYOSCYAMINE; KLONOPIN WAFERS; LANSOPRAZOLE; LOPERAMIDE; LORATADINE; LORAZEPAM; MAXALT MLT; MIRTAZAPINE; NULEV; OLANZAPINE; ONDANSETRON; OXAZEPAM; PARACETAMOL; PIROXICAM; PREVACID SOLUTAB; PSEUDOEPHEDRINE; RISPERDAL M TAB; RISPERIDONE; RIZATRIPTAN; SCOPOLAMINE; SELEGILINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLMITRIPTAN; ZOMIG ZMT;

ALLERGY; ALZHEIMER DISEASE; DEPRESSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; DUODENUM ULCER; FREEZE DRYING; HEADACHE; IRRITABLE COLON; MENTAL DISEASE; MIGRAINE; MOUTH; NAUSEA; NEUROLOGIC DISEASE; ORALLY DISINTEGRATING TABLET; PARKINSON DISEASE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE; SINUSITIS; TABLET FORMULATION; TECHNOLOGY; VOMITING;

EID: 26844451293     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. US Food and Drug Administration, CDER Data Standards Manual, 2003, http://www.fda.gov/cder/dsm/DRG/drg00201.htm, accessed March 19, 2005.
2. European Directorate for the Quality of Medicines, Pharmeuropa, 10 (4), 547 (1988), http://www.pheur.org, accessed March 19, 2005.
3. T.K. Ghosh et al., "Quick Dissolving Oral Dosage Forms: Scientific and Regulatory Considerations from a Clinical Pharmacology and Biopharmaceuticals Perspective," in Drug Delivery to the Oral Cavity: Molecules to Market, T.K. Ghosh and W.R. Pfister, Eds. (CRC Press, New York, NY, 2005), pp. 337-356.
4. L. Dobetti, "Fast-Melting Tablets: Developments and Technologies," Pharm. Technol. 25 (9 Suppl), 44-50 (2001).
5. S.I. Pather, R. Khankari, and J. Siebert, "Quick-Dissolving Intraoral Tablets," in Drug Delivery to the Oral Cavity: Molecules to Market, T.K. Ghosh and W.R. Pfister, Eds. (CRC Press, New York, NY, 2005), pp. 291-336.
6. K. Deepak, "Orally Disintegrating Tablets," Tablets and Capsules 7, 30-35 (2004).
7. D. Brown, "Orally Disintegrating Tablets: Taste Over Speed," Drug Deliv. Technol. 3 (6), 58-61 (2001).
8. H. Seager, "Drug Delivery Products and the Zydis Fast-Dissolving Dosage form," J. Pharm. Pharmacol. 50 (4), 375-382 (1998).
9. FDA, Electronic Orange Book: Approved Drug Products With Therapeutic Equivalence Evaluations Current Through February 2005, http://www.fda.gov/cder/ ob/default.htm, accessed March 18, 2005.
10. T.K. Ghosh, "Quick Dissolving Oral Dosage Forms: Clinical Pharmacology, Biopharmaceutical, and Regulatory Considerations," paper presented at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS), Salt Lake City, UT, Oct. 29, 2003.
11. E.L. Hamilton and E.M. Luts, "Advanced Orally Disintegrating Tablets Bring Significant Benefits to Patients and Product Life Cycles," Drug Deliv. Technol. 5 (1), 34-37 (2005).
12. K. Sharma, W.R. Pfister, and T.K. Ghosh, "Quick-Dispersing Oral Drug Delivery Systems," in Drug Delivery to the Oral Cavity: Molecules to Market, T.K. Ghosh and W.R. Pfister, Eds. (CRC Press, New York, NY, 2005), pp. 261-290.
13. C.C. DeRoche et al., "Consumer Preference for Orally Disintegrating Tablets Over Conventional Forms of Medication: Evolving Methodology for Medication Intake in Dysphagia," lecture presented at the 12th Annual Meeting of the Dysphagia Research Society, San Francisco, CA, Oct. 2-4, 2003.
14. K. Cremer, "Orally Disintegrating Dosage Forms Provide Drug Life Cycle Management Opportunities," Pharm. Technol. 27 (10 Supp), 22-29 (2003).
15. J. Aurora and V. Pathak, "Oral Disintegrating Technologies: Oral Disintegrating Dosage Forms: An Overview," Drug Deliv. Technol. 5 (3), 50-54 (2005).
16. S.V. Sastry and J. Nyshasham, "Process Development and Scale-Up of Oral Fast-Dissolving Tablets," in Drug Delivery to the Oral Cavity: Molecules to Market, T.K. Ghosh and W.R. Pfister, Eds. (CRC Press, New York, NY, 2005), pp. 311-336.
17. W.R. Pfister and T.K. Ghosh, "Intraoral Delivery Systems: An Overview, Current Status and Future Trends," in Drug Delivery to the Oral Cavity: Molecules to Market, T.K. Ghosh and W.R. Pfister, Eds. (CRC Press, New York, NY, 2005), pp. 1-40.
18. K. Ostrander, "Advances in Fast Dispersing Technologies-Zydis," paper presented at the annual meeting of the AAPS, Salt Lake City, UT, Oct. 29, 2003.
19. R.P. Scherer (now Cardinal Health), personal communication, (2005).
20. N. Sharma et al., "Manufacturing Technology Choices for Mouth Dissolving Tablets," Pharm. Technol. 27 (10 Suppl), 10-13 (2003).
21. J. Chu, "Product Development, Scale-Up and Technology Transfer Aspects of Fast Dispersing Dosage Forms-WOWTAB," paper presented at the annual meeting of the AAPS, Salt Lake City, UT, Oct. 29, 2003.
22. V. Agarwal, "Fast Dispersing Dosage Forms: Opportunities and Challenges in Packaging," paper presented at the annual meeting of the AAPS, Salt Lake City, UT, Oct. 29, 2003.
23. S.R. Parakh and A. Gothoskar, "A Review of Mouth Dissolving Tablet Technologies," Pharm. Technol. 27 (11), 92-100 (2003).
24. F. Wehling et al., "Pediatric Effervescent Dosage Form," US Patent 5,223,264 (1993).
25. F. Wehling et al., "Effervescent Dosage Form With Microparticles," US Patent 5,178,878 (1993).
26. F. Wehling and S. Schuehle, "Base Coated Acid Particles and Effervescent Formulation Incorporating Same," US Patent 5,503,846 (1996).
27. J. Hontz, "Development of a Rapidly Dissolving Famotidine Tablet," paper presented at the 41st Annual International Industrial Pharmaceutical Research Conference, Madison, WI, June 1999.
28. R. Yarwood, "Zydis: A Novel, Fast Dissolving Dosage Form," Manuf. Chem. 61, 36-37 (1990).
29. J.A. Fix, "Advances in Quick-Dissolving Tablets Technology Employing WOWTAB," paper presented at the IIR Conference on Drug Delivery Systems, Washington DC, Oct. 1998.
30. M.C. Iles et al., "Freeze-Dried Dosage Forms and Methods for Preparing the Same," US Patent 5,188,825 (1993).
31. P. Kearney and S.K. Wong, "Method for Making Freeze-Dried Drug Dosage Form," US Patent 5,631,023 (1997).
32. G.K.E. Gregory, "Solid Shaped Particles," US Patent 4,758,598 (1988).
33. W. Habib, R. Khankari, and J. Hontz, "Fast-Dissolve Drug Delivery Systems," Crit. Rev. Therap. Drug Carr. Syst. 17, 61-72 (2000).
34. R.H. Bogner, M.F. Wilkosz, and C.T. Storrs, "Fast-Dissolving Tablets," US Pharm. 27 (3), 34-43 (2002).
35. Laboratoire Lafon, "Galenic Form for Oral Administration and its Method of Preparation by Lyophilization of an Oil-in-Water Emulsion," European Patent 0,159,237 (1985).
36. D.J. Gole et al., "Preparation of Pharmaceutical and Other Matrix Systems by Solid-State Dissolution," US Patent 5,215,756 (1993).
37. S.R. Cherukuri et al., "Process for Forming Quickly Dispersing Compressible Unit and Product Therefrom," US Patent 5,587,172 (1996).
38. R. Fuisz, "Ulcer Prevention Method Using a Melt-Spun Hydrogel," US Patent 5,622,717 (1997).
39. S.R. Cherukruri and R. Fuisz, "Process and Apparatus for Making Tablets and Tablets Made Therefrom," European Patent 0,677,147 A2 (1995).
40. G.L. Myers et al., "Delivery of Controlled-Release Systems," US Patent 5,567,439 (1996).
41. G.L. Myers et al., "Apparatus for Making Rapidly Dissolving Dosage Units," US Patent 5,871,781 (1999).
42. S.R. Cherukuri and R. Fuisz, "Process and Apparatus for Making Tablets and Tablets Made Therefrom," US Patent 5,654,003 (1997).
43. G.L. Myers et al., "Ulcer Prevention Method Using a Melt-Spun Hydrogel," US Patent 5,622,719 (1997).
44. T.K. Ghosh, "Orally Disintegrating Tablets," AAPS Newsmagazine, 7 (6), 19-21 (2004).
45. S.V. Sastry, "An Overview of Fast Dispersing Technologies," paper presented at the annual meeting of the AAPS, Oct. 29, 2003.